GIM
BPMC
Granahan Investment Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-144,756
| Closed | -$12.8M | – | 157 |
|
|
2025
Q1 | $12.8M | Buy |
144,756
+2,866
| +2% | +$254K | 0.64% | 52 |
|
|
2024
Q4 | $12.4M | Buy |
141,890
+10,744
| +8% | +$937K | 0.52% | 55 |
|
|
2024
Q3 | $12.1M | Sell |
131,146
-8,586
| -6% | -$794K | 0.48% | 66 |
|
|
2024
Q2 | $15.1M | Sell |
139,732
-39,585
| -22% | -$4.27M | 0.6% | 48 |
|
|
2024
Q1 | $17M | Buy |
179,317
+11,810
| +7% | +$1.12M | 0.6% | 53 |
|
|
2023
Q4 | $15.5M | Sell |
167,507
-61,740
| -27% | -$5.69M | 0.51% | 62 |
|
|
2023
Q3 | $11.5M | Buy |
229,247
+44,744
| +24% | +$2.25M | 0.41% | 74 |
|
|
2023
Q2 | $11.7M | Sell |
184,503
-47,716
| -21% | -$3.02M | 0.36% | 77 |
|
|
2023
Q1 | $10.4M | Buy |
232,219
+7,405
| +3% | +$333K | 0.32% | 87 |
|
|
2022
Q4 | $9.85M | Buy |
224,814
+80,637
| +56% | +$3.53M | 0.3% | 92 |
|
|
2022
Q3 | $9.5M | Buy |
144,177
+40,531
| +39% | +$2.67M | 0.31% | 89 |
|
|
2022
Q2 | $5.24M | Sell |
103,646
-53,000
| -34% | -$2.68M | 0.18% | 117 |
|
|
2022
Q1 | $10M | Buy |
156,646
+105,921
| +209% | +$6.77M | 0.25% | 90 |
|
|
2021
Q4 | $5.43M | Sell |
50,725
-2,072
| -4% | -$222K | 0.11% | 147 |
|
|
2021
Q3 | $5.43M | Sell |
52,797
-9,481
| -15% | -$975K | 0.1% | 143 |
|
|
2021
Q2 | $5.48M | Buy |
62,278
+3,371
| +6% | +$297K | 0.1% | 149 |
|
|
2021
Q1 | $5.73M | Sell |
58,907
-38,875
| -40% | -$3.78M | 0.12% | 133 |
|
|
2020
Q4 | $11M | Sell |
97,782
-30,777
| -24% | -$3.45M | 0.25% | 85 |
|
|
2020
Q3 | $11.9M | Buy |
128,559
+17,833
| +16% | +$1.65M | 0.4% | 73 |
|
|
2020
Q2 | $8.64M | Buy |
+110,726
| New | +$8.64M | 0.31% | 89 |
|